These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22310273)

  • 1. Abnormal ¹³¹I uptake in a benign serous ovarian cystadenoma mimicking bladder physiological uptake.
    Song HJ; Xue YL; Xu YH; Qiu ZL; Luo QY
    Clin Nucl Med; 2012 Mar; 37(3):e59-60. PubMed ID: 22310273
    [No Abstract]   [Full Text] [Related]  

  • 2. 131I uptake in a benign serous cystadenoma of the ovary.
    Kim EE; Pjura G; Gobuty A; Verani R
    Eur J Nucl Med; 1984; 9(9):433-5. PubMed ID: 6499878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign ovarian serous cystadenoma mimicking papillary thyroid carcinoma metastasis on I-131 SPECT/CT.
    Haaga TL; Yoo DC; Ortiz R; Noto RB
    Med Health R I; 2012 Feb; 95(2):57-9. PubMed ID: 22474878
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal iodine-131 uptake in a benign mucinous ovarian cystadenoma mimicking struma ovarii.
    Morel O; Rohmer V; Girault S; Muratet JP; Berthelot C; Jallet P
    Clin Nucl Med; 2007 Jan; 32(1):64-6. PubMed ID: 17179812
    [No Abstract]   [Full Text] [Related]  

  • 5. Peroperative detection with a gamma probe of pelvic metastasis after differentiated thyroid carcinoma in female patients: about two cases and management reflections.
    Pirvu A; Guigard S; Blaise H; Chaffanjon P
    Chirurgia (Bucur); 2013; 108(1):126-9. PubMed ID: 23464784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SPECT/CT in differentiated thyroid cancer.
    Barwick TD; Dhawan RT; Lewington V
    Nucl Med Commun; 2012 Aug; 33(8):787-98. PubMed ID: 22669053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone metastasis from thyroid cancer diagnosed by I-131 whole-body scan without identifiable lesion in the thyroid.
    Wang J; Liu B; Zhao Z; Kuang A
    Clin Nucl Med; 2011 Nov; 36(11):1033-5. PubMed ID: 21975397
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis of struma ovarii in a patient with papillary thyroid carcinoma--verification via 124I-PET/US fusion.
    Freesmeyer M; Schleußner E; Winkens T
    Ultraschall Med; 2014 Aug; 35(4):368-70. PubMed ID: 24458572
    [No Abstract]   [Full Text] [Related]  

  • 9. Computed tomography of benign ovarian masses.
    Sawyer RW; Vick CW; Walsh JW; McClure PH
    J Comput Assist Tomogr; 1985; 9(4):784-9. PubMed ID: 4019837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of ovarian benign and malignant tumors by CT.
    Rohde U; Steinbrich W
    J Belge Radiol; 1983; 66(1):9-14. PubMed ID: 6619093
    [No Abstract]   [Full Text] [Related]  

  • 11. Pitfalls of I-131 whole body scan interpretation: bronchogenic cyst and mucinous cystadenoma.
    Agriantonis DJ; Hall L; Wilson MA
    Clin Nucl Med; 2008 May; 33(5):325-7. PubMed ID: 18431144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual ¹³¹I uptake in a benign mucinous cystadenoma of the ovary in a patient with papillary thyroid cancer.
    Qiu ZL; Xu YH; Song HJ; Luo QY
    Clin Nucl Med; 2010 Dec; 35(12):965-6. PubMed ID: 21206234
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG PET/CT in serous psammocarcinoma of the ovary.
    Dong A; Wang Y; Zuo C
    Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging struma ovarii by means of 124I-Na PET/CT.
    Lopci E; Colombo P; Rodari M; Lania A; Vitobello D; Leonardi L; Chiti A
    Nucl Med Rev Cent East Eur; 2013; 16(2):95-6. PubMed ID: 24068641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive I-131 uptake by an ovarian serous cystadenofibroma.
    Flug J; Lameka K; Lee R; Katz DS; Sung WW; Yung E
    Clin Nucl Med; 2012 Feb; 37(2):178-80. PubMed ID: 22228346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic imaging of ovarian tumors with carbon-11-methionine: a PET study.
    Lapela M; Leskinen-Kallio S; Varpula M; Grénman S; Salmi T; Alanen K; Någren K; Lehikoinen P; Ruotsalainen U; Teräs M
    J Nucl Med; 1995 Dec; 36(12):2196-200. PubMed ID: 8523104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients with differentiated thyroid carcinoma undergo 131I SPECT-CT scanning rather than 131I whole-body scanning?
    Al Balooshi B; Vinjamuri S
    Nucl Med Commun; 2015 Jun; 36(6):549-52. PubMed ID: 25906202
    [No Abstract]   [Full Text] [Related]  

  • 18. Computed tomography of malignant pheochromocytoma of the bladder. A case report.
    Frennby B; Aspelin P; Udén P; Nyman U
    Rofo; 1990 Aug; 153(2):225-7. PubMed ID: 2168084
    [No Abstract]   [Full Text] [Related]  

  • 19. FDG accumulation in obturator herniation of the bladder mimicking metastatic disease.
    Kaneta T; Takanami K; Mitamura A; Hiraide T; Fukuda H; Yamada S; Takahashi S
    Clin Nucl Med; 2009 Jun; 34(6):395-7. PubMed ID: 19487858
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.
    Wakabayashi H; Nakajima K; Fukuoka M; Inaki A; Nakamura A; Kayano D; Kinuya S
    Ann Nucl Med; 2011 Nov; 25(9):609-15. PubMed ID: 21725630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.